Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Evidence-based treatment with somatostatin analogues in polycystic liver disease

Gevers, T.J.G.

Publication date

January 2015

Publisher

[S.l. : s.n.]

Abstract

Contains fulltext : 140187.pdf (publisher's version ) (Open Access)12 mei 2015Promotor : Drenth, J.P.H

Extracted data

Related items

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial.

Chrispijn, M.
Drenth, J.P.H.

January 2011

Contains fulltext : 97893.pdf (publisher's version ) (Open Access)ABSTRACT: BACKGR...

Supplementary_Material – Supplemental material for Drug holiday in patients with polycystic liver disease treated with somatostatin analogues

René M. M. van Aerts (5822756)
Marieke Kolkman (5822759)
Wietske Kievit (176181)
Tom J. G. Gevers (5822762)
Frederik Nevens (243993)
Joost P. H. Drenth (161484)

October 2018

Supplemental material, Supplementary_Material for Drug holiday in patients with polycystic liver dis...

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management

Cnossen, W.R.
Drenth, J.P.H.

January 2014

Contains fulltext : 136540.pdf (publisher's version ) (Open Access)Polycystic live...

Somatostatin analogues reduce liver volume in polycystic liver disease.

Keimpema, L. van
Man, R.A. de
Drenth, J.P.H.

January 2008

Contains fulltext : 71004.pdf (publisher's version ) (Closed access

Polycystic liver disease: Clinical characterisation and evidence based treatment development

D'Agnolo, H.M.A.

January 2017

Contains fulltext : 167172.pdf (publisher's version ) (Open Access)Radboud Univers...

Treatment of polycystic liver disease.

Keimpema, L. van
Hockerstedt, K.

January 2009

Contains fulltext : 81066.pdf (publisher's version ) (Closed access

Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials

Neijenhuis, MK
Gevers, TJG
Nevens, Frederik
Hogan, MC
Torres, VE
Kievit, W
Drenth, JPH

September 2015

Polycystic liver disease is associated with impaired health-related quality of life (HRQL). Somatost...

Novel genetic approaches in polycystic liver disease

Cnossen, W.R.

January 2015

Contains fulltext : 145297.pdf (publisher's version ) (Open Access)16 november 201...

Medical and surgical treatment options for polycystic liver disease.

Drenth, J.P.H.
Chrispijn, M.
Nagorney, D.M.
Kamath, P.S.
Torres, V.E.

January 2010

Contains fulltext : 87636.pdf (publisher's version ) (Closed access)1 december 201

Somatostatin analogues for treatment of polycystic liver disease

Gevers, T.J.G.
Drenth, J.P.H.

January 2011

Item does not contain fulltextPURPOSE OF REVIEW: The present review summarizes the existing knowledg...

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues

Aerts, R.M.M. van
Kolkman, M.
Kievit, W.
Gevers, T.J.G.
Nevens, F.
Drenth, J.P.H.

January 2018

Contains fulltext : 200059.pdf (publisher's version ) (Open Access)Background: Som...

Patient-reported health in polycystic liver disease

Neijenhuis, M.K.

January 2017

Contains fulltext : 169257.pdf (publisher's version ) (Open Access)Radboud Univers...

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

Keimpema, L. van
Nevens, F.
Vanslembrouck, R.
Oijen, M.G.H. van
Hoffmann, A.L.
Dekker, H.M.
Man, R.A. de
Drenth, J.P.H.

January 2009

Contains fulltext : 80007.pdf (publisher's version ) (Closed access)BACKGROUND & A...

Analysis of multiple invasive and non invasive therapeutic options for polycystic livers. Call for a Yielding Single Treatment Strategy.

Keimpema, L. van

January 2010

Contains fulltext : 76529.pdf (publisher's version ) (Open Access)This thesis desc...

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

Aerts, R.M.M. van
Kievit, W.
D'Agnolo, H.M.
Blijdorp, C.J.
Casteleijn, N.F.
Dekker, Shosha E., I
Laarschot, L.F.M. van de
Wetzels, J.
Gansevoort, R.T.
Drenth, J.P.H.

January 2019

Contains fulltext : 206162.pdf (publisher's version ) (Closed access

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial.

Chrispijn, M.
Drenth, J.P.H.

January 2011

Contains fulltext : 97893.pdf (publisher's version ) (Open Access)ABSTRACT: BACKGR...

Supplementary_Material – Supplemental material for Drug holiday in patients with polycystic liver disease treated with somatostatin analogues

René M. M. van Aerts (5822756)
Marieke Kolkman (5822759)
Wietske Kievit (176181)
Tom J. G. Gevers (5822762)
Frederik Nevens (243993)
Joost P. H. Drenth (161484)

October 2018

Supplemental material, Supplementary_Material for Drug holiday in patients with polycystic liver dis...

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management

Cnossen, W.R.
Drenth, J.P.H.

January 2014

Contains fulltext : 136540.pdf (publisher's version ) (Open Access)Polycystic live...

Somatostatin analogues reduce liver volume in polycystic liver disease.

Keimpema, L. van
Man, R.A. de
Drenth, J.P.H.

January 2008

Contains fulltext : 71004.pdf (publisher's version ) (Closed access

Polycystic liver disease: Clinical characterisation and evidence based treatment development

D'Agnolo, H.M.A.

January 2017

Contains fulltext : 167172.pdf (publisher's version ) (Open Access)Radboud Univers...

Treatment of polycystic liver disease.

Keimpema, L. van
Hockerstedt, K.

January 2009

Contains fulltext : 81066.pdf (publisher's version ) (Closed access

Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials

Neijenhuis, MK
Gevers, TJG
Nevens, Frederik
Hogan, MC
Torres, VE
Kievit, W
Drenth, JPH

September 2015

Polycystic liver disease is associated with impaired health-related quality of life (HRQL). Somatost...

Novel genetic approaches in polycystic liver disease

Cnossen, W.R.

January 2015

Contains fulltext : 145297.pdf (publisher's version ) (Open Access)16 november 201...

Medical and surgical treatment options for polycystic liver disease.

Drenth, J.P.H.
Chrispijn, M.
Nagorney, D.M.
Kamath, P.S.
Torres, V.E.

January 2010

Contains fulltext : 87636.pdf (publisher's version ) (Closed access)1 december 201

Somatostatin analogues for treatment of polycystic liver disease

Gevers, T.J.G.
Drenth, J.P.H.

January 2011

Item does not contain fulltextPURPOSE OF REVIEW: The present review summarizes the existing knowledg...

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues

Aerts, R.M.M. van
Kolkman, M.
Kievit, W.
Gevers, T.J.G.
Nevens, F.
Drenth, J.P.H.

January 2018

Contains fulltext : 200059.pdf (publisher's version ) (Open Access)Background: Som...

Patient-reported health in polycystic liver disease

Neijenhuis, M.K.

January 2017

Contains fulltext : 169257.pdf (publisher's version ) (Open Access)Radboud Univers...

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

Keimpema, L. van
Nevens, F.
Vanslembrouck, R.
Oijen, M.G.H. van
Hoffmann, A.L.
Dekker, H.M.
Man, R.A. de
Drenth, J.P.H.

January 2009

Contains fulltext : 80007.pdf (publisher's version ) (Closed access)BACKGROUND & A...

Analysis of multiple invasive and non invasive therapeutic options for polycystic livers. Call for a Yielding Single Treatment Strategy.

Keimpema, L. van

January 2010

Contains fulltext : 76529.pdf (publisher's version ) (Open Access)This thesis desc...

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

Aerts, R.M.M. van
Kievit, W.
D'Agnolo, H.M.
Blijdorp, C.J.
Casteleijn, N.F.
Dekker, Shosha E., I
Laarschot, L.F.M. van de
Wetzels, J.
Gansevoort, R.T.
Drenth, J.P.H.

January 2019

Contains fulltext : 206162.pdf (publisher's version ) (Closed access

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial.

Chrispijn, M.
Drenth, J.P.H.

January 2011

Contains fulltext : 97893.pdf (publisher's version ) (Open Access)ABSTRACT: BACKGR...

Supplementary_Material – Supplemental material for Drug holiday in patients with polycystic liver disease treated with somatostatin analogues

René M. M. van Aerts (5822756)
Marieke Kolkman (5822759)
Wietske Kievit (176181)
Tom J. G. Gevers (5822762)
Frederik Nevens (243993)
Joost P. H. Drenth (161484)

October 2018

Supplemental material, Supplementary_Material for Drug holiday in patients with polycystic liver dis...

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management

Cnossen, W.R.
Drenth, J.P.H.

January 2014

Contains fulltext : 136540.pdf (publisher's version ) (Open Access)Polycystic live...